In mice, hepatic overexpression of human HSD17B13 increases liver TAG and cholesterol levels (87), while abrogation of the mouse Hsd17b13 gene was reported to both promote hepatic steatosis and inflammation (88) or to have limited effects on MASH (89). This evidence concerns the gene HSD17B13 and fatty liver disease.